SGI
TMO icon

Summit Global Investments’s Thermo Fisher Scientific TMO Stock Holding History

Summit Global Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$827K Sell
1,683
-174
-9% -$94.4K 0.05% 226
2025
Q4 		$1.08M Buy
+1,857
New +$1.05M 0.06% 186
2024
Q4 		– Sell
-443
Closed -$274K – 637
2024
Q3 		$274K Sell
443
-1
-0.2% -$592 0.02% 433
2024
Q2 		$246K Sell
444
-160
-26% -$91.7K 0.02% 444
2024
Q1 		$351K Sell
604
-749
-55% -$420K 0.03% 382
2023
Q4 		$718K Sell
1,353
-39
-3% -$18.9K 0.05% 280
2023
Q3 		$704K Buy
1,392
+303
+28% +$161K 0.05% 282
2023
Q2 		$568K Sell
1,089
-3
-0.3% -$1.62K 0.04% 318
2023
Q1 		$629K Buy
1,092
+283
+35% +$160K 0.05% 315
2022
Q4 		$445K Buy
809
+9
+1% +$4.77K 0.04% 335
2022
Q3 		$406K Buy
800
+7
+0.9% +$3.92K 0.04% 354
2022
Q2 		$431K Sell
793
-18
-2% -$9.91K 0.04% 343
2022
Q1 		$479K Buy
811
+194
+31% +$111K 0.04% 340
2021
Q4 		$412K Buy
617
+25
+4% +$15.6K 0.03% 400
2021
Q3 		$338K Buy
592
+4
+0.7% +$2.19K 0.03% 375
2021
Q2 		$298K Sell
588
-121
-17% -$57.1K 0.02% 461
2021
Q1 		$324K Buy
709
+113
+19% +$53.9K 0.02% 447
2020
Q4 		$277K Buy
596
+105
+21% +$49.2K 0.03% 230
2020
Q3 		$217K Buy
+491
New +$203K 0.02% 237
2018
Q2 		– Sell
-3,736
Closed -$771K – 320
2018
Q1 		$771K Sell
3,736
-123
-3% -$25.8K 0.12% 90
2017
Q4 		$733K Sell
3,859
-3,301
-46% -$632K 0.11% 116
2017
Q3 		$1.35M Buy
7,160
+3,630
+103% +$657K 0.21% 70
2017
Q2 		$616K Buy
3,530
+780
+28% +$131K 0.18% 107
2017
Q1 		$422K Buy
2,750
+250
+10% +$38.2K 0.14% 172
2016
Q4 		$353K Buy
+2,500
New +$369K 0.13% 192

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Summit Global Investments's TMO Position: Q1 2026 in Review

Summit Global Investments reduced its Thermo Fisher Scientific (TMO) stake by 9.4% in Q1 2026, selling an estimated $94.4K and leaving 1,683 shares worth $827K. The position accounts for 0.05% of the portfolio, ranked #226.

Summit Global Investments first reported a position in TMO in Q4 2016 and has held it in 25 quarters since. The position peaked at $1.35M in Q3 2017. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Summit Global Investments held 1,683 shares of Thermo Fisher Scientific worth $827K as of Q1 2026.
  • Summit Global Investments sold 174 Thermo Fisher Scientific shares in Q1 2026, an estimated $94.4K.
  • Thermo Fisher Scientific made up 0.05% of Summit Global Investments's portfolio in Q1 2026, its #226 holding.
  • Summit Global Investments first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 25 quarters since.
  • Summit Global Investments's Thermo Fisher Scientific position peaked at $1.35M in Q3 2017.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.